Literature DB >> 21460487

Development and validation of a Clostridium difficile infection risk prediction model.

Erik R Dubberke1, Yan Yan, Kimberly A Reske, Anne M Butler, Joshua Doherty, Victor Pham, Victoria J Fraser.   

Abstract

OBJECTIVE: To develop and validate a risk prediction model that could identify patients at high risk for Clostridium difficile infection (CDI) before they develop disease. DESIGN AND
SETTING: Retrospective cohort study in a tertiary care medical center. PATIENTS: Patients admitted to the hospital for at least 48 hours during the calendar year 2003.
METHODS: Data were collected electronically from the hospital's Medical Informatics database and analyzed with logistic regression to determine variables that best predicted patients' risk for development of CDI. Model discrimination and calibration were calculated. The model was bootstrapped 500 times to validate the predictive accuracy. A receiver operating characteristic curve was calculated to evaluate potential risk cutoffs.
RESULTS: A total of 35,350 admitted patients, including 329 with CDI, were studied. Variables in the risk prediction model were age, CDI pressure, times admitted to hospital in the previous 60 days, modified Acute Physiology Score, days of treatment with high-risk antibiotics, whether albumin level was low, admission to an intensive care unit, and receipt of laxatives, gastric acid suppressors, or antimotility drugs. The calibration and discrimination of the model were very good to excellent (C index, 0.88; Brier score, 0.009).
CONCLUSIONS: The CDI risk prediction model performed well. Further study is needed to determine whether it could be used in a clinical setting to prevent CDI-associated outcomes and reduce costs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21460487      PMCID: PMC3649761          DOI: 10.1086/658944

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  35 in total

Review 1.  Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve.

Authors:  Nancy R Cook
Journal:  Clin Chem       Date:  2007-11-16       Impact factor: 8.327

2.  Strategies to prevent clostridium difficile infections in acute care hospitals.

Authors:  Erik R Dubberke; Dale N Gerding; David Classen; Kathleen M Arias; Kelly Podgorny; Deverick J Anderson; Helen Burstin; David P Calfee; Susan E Coffin; Victoria Fraser; Frances A Griffin; Peter Gross; Keith S Kaye; Michael Klompas; Evelyn Lo; Jonas Marschall; Leonard A Mermel; Lindsay Nicolle; David A Pegues; Trish M Perl; Sanjay Saint; Cassandra D Salgado; Robert A Weinstein; Robert Wise; Deborah S Yokoe
Journal:  Infect Control Hosp Epidemiol       Date:  2008-10       Impact factor: 3.254

3.  Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy.

Authors:  Sandra Dial; J A Chris Delaney; Verena Schneider; Samy Suissa
Journal:  CMAJ       Date:  2006-09-26       Impact factor: 8.262

4.  Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach.

Authors:  Carlene A Muto; Mary Kathleen Blank; Jane W Marsh; Emanuel N Vergis; Mary M O'Leary; Kathleen A Shutt; Anthony W Pasculle; Marian Pokrywka; Juliet G Garcia; Kathy Posey; Terri L Roberts; Brian A Potoski; Gary E Blank; Richard L Simmons; Peter Veldkamp; Lee H Harrison; David L Paterson
Journal:  Clin Infect Dis       Date:  2007-10-09       Impact factor: 9.079

5.  Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease.

Authors:  Erik R Dubberke; Kimberly A Reske; Margaret A Olsen; Kathleen M McMullen; Jennie L Mayfield; L Clifford McDonald; Victoria J Fraser
Journal:  Arch Intern Med       Date:  2007-05-28

6.  Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients.

Authors:  Erik R Dubberke; Kimberly A Reske; Margaret A Olsen; L Clifford McDonald; Victoria J Fraser
Journal:  Clin Infect Dis       Date:  2008-02-15       Impact factor: 9.079

7.  Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors.

Authors:  Erik R Dubberke; Kimberly A Reske; Yan Yan; Margaret A Olsen; L Clifford McDonald; Victoria J Fraser
Journal:  Clin Infect Dis       Date:  2007-12-15       Impact factor: 9.079

8.  A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.

Authors:  K W Garey; T K Dao-Tran; Z D Jiang; M P Price; L O Gentry; H L Dupont
Journal:  J Hosp Infect       Date:  2008-08-23       Impact factor: 3.926

9.  Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003.

Authors:  L Clifford McDonald; Maria Owings; Daniel B Jernigan
Journal:  Emerg Infect Dis       Date:  2006-03       Impact factor: 6.883

10.  Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients.

Authors:  Erik R Dubberke; Anne M Butler; Kimberly A Reske; Denis Agniel; Margaret A Olsen; Gina D'Angelo; L Clifford McDonald; Victoria J Fraser
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

View more
  29 in total

Review 1.  Clostridium difficile in the ICU: the struggle continues.

Authors:  Linda D Bobo; Erik R Dubberke; Marin Kollef
Journal:  Chest       Date:  2011-12       Impact factor: 9.410

2.  Gender Differences in Non-Toxigenic Clostridium difficile Colonization and Risk of Subsequent C. difficile Infection.

Authors:  Mukil Natarajan; Mary Am Rogers; Jacob Bundy; Dejan Micic; Seth T Walk; Kavitha Santhosh; Krishna Rao; Spencer Winters; Vincent B Young; David M Aronoff
Journal:  Clin Res Infect Dis       Date:  2015-08-03

3.  Prevalence and duration of asymptomatic Clostridium difficile carriage among healthy subjects in Pittsburgh, Pennsylvania.

Authors:  Alison L Galdys; Jemma S Nelson; Kathleen A Shutt; Jessica L Schlackman; Diana L Pakstis; A William Pasculle; Jane W Marsh; Lee H Harrison; Scott R Curry
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

4.  Leveraging Clinical Time-Series Data for Prediction: A Cautionary Tale.

Authors:  Eli Sherman; Hitinder Gurm; Ulysses Balis; Scott Owens; Jenna Wiens
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

5.  Predicting the risk for hospital-onset Clostridium difficile infection (HO-CDI) at the time of inpatient admission: HO-CDI risk score.

Authors:  Ying P Tabak; Richard S Johannes; Xiaowu Sun; Carlos M Nunez; L Clifford McDonald
Journal:  Infect Control Hosp Epidemiol       Date:  2015-03-10       Impact factor: 3.254

6.  Clostridium difficile infection among hospitalized HIV-infected individuals: epidemiology and risk factors: results from a case-control study (2002-2013).

Authors:  Stefano Di Bella; Alexander W Friedrich; Esther García-Almodóvar; Maria Serena Gallone; Fabrizio Taglietti; Simone Topino; Vincenzo Galati; Emma Johnson; Silvia D'Arezzo; Nicola Petrosillo
Journal:  BMC Infect Dis       Date:  2015-04-22       Impact factor: 3.090

7.  Prediction of Recurrent Clostridium Difficile Infection Using Comprehensive Electronic Medical Records in an Integrated Healthcare Delivery System.

Authors:  Gabriel J Escobar; Jennifer M Baker; Patricia Kipnis; John D Greene; T Christopher Mast; Swati B Gupta; Nicole Cossrow; Vinay Mehta; Vincent Liu; Erik R Dubberke
Journal:  Infect Control Hosp Epidemiol       Date:  2017-08-24       Impact factor: 3.254

Review 8.  Stress Ulcer Prophylaxis in Neurocritical Care.

Authors:  Jeffrey F Barletta; Alicia J Mangram; Joseph F Sucher; Victor Zach
Journal:  Neurocrit Care       Date:  2018-12       Impact factor: 3.210

9.  Probiotics for Prevention of Clostridium difficile Infection in Hospitalized Patients: Is the Jury Still Out?

Authors:  Krishna Rao; Vincent B Young
Journal:  Gastroenterology       Date:  2017-04-28       Impact factor: 22.682

Review 10.  Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Krishna Rao; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2016-07       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.